Recent progress in cancer care continue to present hope for patients. Investigators are diligently exploring novel approaches, including immune therapies , targeted treatments , and individualized medicine . A major finding published this week highlights the potential of a new drug in combating late-stage NSCLC. Furthermore, continued trials are fo